CAT and chronic myelogenous leukemia, BCR-ABL1 positive: CAT activity was decreased by 37.6% (p < 0.001, Figure 1b) and GPx activity by 16.4% (p < 0.05, Figure 1b) in CML erythrocytes compared to controls.